Island Pharmaceuticals Ltd has released a press release.
Ongoing engagement with the US FDA
Filed with ASX ·
6ix hasn’t read this filing yet.
Island Pharmaceuticals Ltd on 6ix
Story so far
Earlier from Island Pharmaceuticals
- Agreement with Texas Biomed for Galidesivir Program
- Island expands Galidesivir IP with US Patent Grant
- Additional FDA Submission completed for Galidesivir
- Options exercised raises $1million
- Coalition acceptance to advance US procurement & stockpiling
Later from Island Pharmaceuticals
- US Patent Granted for Galidesivir in filoviridae viruses
- Quarterly Appendix 4C and Activities Report
- FDA confirms Galidesivir approval pathway
- $9m placement to advance US biodefence opportunity
- Response to ASX Query Letter
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals